definiens: means, with r espect to Licensed Products, the carrying out of development and commercialization activities using the efforts that a company within the pharmaceutica l industry and similarly situated to [COMPANY] would rea sonably devote to a product of similar market poten tial or profit potential resulting from its own research ef forts, based on conditions then prevailing and taki ng into account, without limitation, issues of safety and e fficacy, product profile, the proprietary position, the then current competitive environment for such product an d the likely timing of such product ’s entry into th e market, the regulatory environment and status of such produ ct, and other relevant scientific, technical and co mmercial factors, 1.6 means all Technology, chemical or biological materials, marketing plans, strategies and customer lists, and other informatio n that are disclosed or provided by such Party or i ts Affiliates to the other Party or its Affiliates, regardless of whether any of the foregoing are marked or or communicated to the other by the d isclosing Party or its Affiliates in oral, written, graphic, or electronic form